Zeo ScientifiX (ZEOX) Share-based Compensation Growth (5y) (2022 - 2026)
Zeo ScientifiX (ZEOX) Share-based Compensation Growth (5y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -13.62% |
| Jan 31, 2026 | -29.89% |
| Oct 31, 2025 | -2.88% |
| Jul 31, 2025 | -18.53% |
| Apr 30, 2025 | 9.41% |
| Jan 31, 2025 | 63.46% |
| Oct 31, 2024 | 46.61% |
| Jul 31, 2024 | 31.00% |
| Apr 30, 2024 | 35.03% |
| Jan 31, 2024 | 69.18% |
| Oct 31, 2023 | 56.91% |
| Jul 31, 2023 | 71.20% |
| Apr 30, 2023 | -28.92% |
| Jan 31, 2023 | 62.79% |
| Oct 31, 2022 | 65.15% |
| Jul 31, 2022 | 55.00% |
| Apr 30, 2022 | -33.12% |
| Jan 31, 2022 | -31.73% |